SECreport

Form 4 Cue Biopharma, Inc. For: Jan 02 Filed by: Simon Barry J.

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases